Depo-Provera Contraceptive Failure Rate
Depo-Provera (depot medroxyprogesterone acetate) has a typical use failure rate of 6% and a perfect use failure rate of 0.2-0.3%, making it 94% effective with typical use but over 99% effective with perfect adherence to the 12-week injection schedule. 1
Failure Rate Data by Use Pattern
The distinction between typical and perfect use is critical for understanding Depo-Provera's real-world effectiveness:
- Typical use failure rate: 6% - This reflects actual pregnancy rates when women may miss or delay appointments for their quarterly injections 1, 2, 3
- Perfect use failure rate: 0.2-0.3% - This represents effectiveness when injections are administered precisely every 12 weeks 1, 2, 3
- Continuation rate: 56% at one year - This is notably the lowest among highly effective reversible contraceptives, meaning nearly half of women discontinue within the first year 1, 4
Clinical Context and Comparative Effectiveness
The 6% typical use failure rate places Depo-Provera in an intermediate effectiveness category, significantly less effective than long-acting reversible contraceptives (LARCs) in real-world use:
- Nexplanon (implant): 0.05% typical use failure rate - Nearly 100 times more effective than Depo-Provera in typical use 2, 3
- Mirena (hormonal IUD): 0.2% typical use failure rate - Approximately 30 times more effective than Depo-Provera in typical use 2, 3
- Combined oral contraceptives: 9% typical use failure rate - Slightly less effective than Depo-Provera 1
The key difference is that LARCs eliminate user adherence issues entirely, whereas Depo-Provera requires women to remember quarterly appointments, and the gap between perfect and typical use reflects missed or delayed injections 2, 3.
Real-World Pregnancy Data
Population-based studies provide additional context on actual failure rates:
- A Planned Parenthood review found a crude rate of 0.42 pregnancies per 1,000 women per year among Depo-Provera users, though 45% of pregnancies occurred after the injection window had expired 5
- A New Zealand population study reported only 0.9 pregnancies per 100 woman-years, with contraceptive failure accounting for just 1.6% of discontinuations 6
- These lower observed rates likely reflect that many "failures" are actually due to missed injections rather than true method failure 5
Critical Timing Requirements
Depo-Provera must be administered every 12 weeks (84 days ± 5 days) to maintain contraceptive effectiveness. 1 The typical use failure rate of 6% primarily reflects pregnancies that occur when women delay or miss their scheduled injections beyond this window 1.
Important Clinical Caveats
Several factors contribute to the gap between perfect and typical use effectiveness:
- Poor continuation rates driven by menstrual irregularities, weight gain concerns, and bone density warnings lead to discontinuation and subsequent pregnancy risk 4, 6, 7
- Delayed pregnancy recognition - 46% of pregnancies during Depo-Provera use were diagnosed after the first trimester, and 19% of women received additional injections while already pregnant 5
- Return to fertility delay of up to 18 months after discontinuation may paradoxically contribute to unintended pregnancies when women stop the method 1
The American College of Obstetricians and Gynecologists emphasizes that pre-injection counseling about menstrual changes significantly improves continuation rates, which directly impacts real-world effectiveness 4.